id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-P-0587-0001,FDA,FDA-2009-P-0587,Buchanan Ingersoll & Rooney PC -  Citizen Petition,Other,CP-Citizen Petition,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:55Z,,0,0,0900006480a6777c
FDA-2009-P-0587-0002,FDA,FDA-2009-P-0587,"Attachment 1 - ""FDA Response to the Honorable Charles E. Grassley, May 14, 2008"" - [Buchanan Ingersoll & Rooney PC -  Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-12-14T05:00:00Z,2009,12,,,2009-12-15T01:16:52Z,,0,0,0900006480a6777d
FDA-2009-P-0587-0003,FDA,FDA-2009-P-0587,"Attachment 2 - ""Listing of Arcticles From PubMed That Discuss Folic Acid and Neural Tube Defects During Pregency"" - [Buchanan Ingersoll & Rooney PC -  Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-12-14T05:00:00Z,2009,12,,,2009-12-15T01:16:53Z,,0,0,0900006480a6777e
FDA-2009-P-0587-0004,FDA,FDA-2009-P-0587,Acknowledgement Letter to Buchanan Ingersoll & Rooney PC,Other,ACK-Acknowledgement Letter,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-08-11T03:05:50Z,,0,0,0900006480a67922